Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated anti-tumor efficacy of tafasitamab
Biedermann, Alexander, Patra-Kneuer, Maria, Mougiakakos, Dimitrios, Büttner-Herold, Maike, Mangelberger-Eberl, Doris, Berges, Johannes, Kellner, Christian, Altmeyer, Sarah, Bittenbring, Jörg Thomas, Augsberger, Christian, Ilieva-Babinsky, Kristina, Haskamp, Stefan, Beier, Fabian, Lischer, Christopher, Vera, Julio, Lührmann, Anja, Bertz, Simone, Völkl, Simon, Jacobs, Benedikt, Steidl, Stefan, Mackensen, Andreas, Bruns, Heiko
Published in Haematologica (Roma) (27.06.2024)
Published in Haematologica (Roma) (27.06.2024)
Get full text
Journal Article
Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis
Biedermann, Alexander, Mangelberger-Eberl, Doris, Mougiakakos, Dimitrios, Büttner-Herold, Maike, Flamann, Cindy, Kellner, Christian, Altmeyer, Sarah, Bittenbring, Jörg, Augsberger, Christian, Patra-Kneuer, Maria, Landgraf, Karin, Ilieva-Babinsky, Kristina, Haskamp, Stefan, Beier, Fabian, Voelkl, Simon, Pallasch, Christian, Jacobs, Benedikt, Steidl, Stefan, Heitmüller, Christina, Mackensen, Andreas, Bruns, Heiko
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
CD19 Antigen Occupancy on Cancer Cells with the CD19 Monoclonal Antibody Tafasitamab Improves the Activation, Antitumor Efficacy, and Safety Profile of CART19 Cell Therapy
Sakemura, Reona Leo, Manriquez-Roman, Claudia, Horvei, Paulina, Cox, Michelle J., Huynh, Truc, Girsch, James H., Sirpilla, Olivia, Yun, Kun, Stewart, Carli M., Can, Ismail, Ogbodo, Ekene J., Adada, Mohamad M., Kankeu Fonkoua, Lionel A., Hefazi, Mehrdad, Ruff, Michael W., Ilieva-Babinsky, Kristina, Augsberger, Christian, Patra-Kneuer, Maria, Heitmüller, Christina, Steidl, Stefan, Parikh, Sameer A., Ding, Wei, Kay, Neil E., Nowakowski, Grzegorz S., Siegler, Elizabeth L., Kenderian, Saad S.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Transient CD19 Occupancy with Tafasitamab at the Time of Anti-CD19 Chimeric Antigen Receptor T (CART19) Cell Infusion Diminishes Severity and Incidence of CRS and Improves the Therapeutic Index of CART19 Cell Therapy in Preclinical Models
Sakemura, R. Leo, Roman, Claudia Manriquez, Horvei, Paulina, Huynh, Truc N, Girsch, James H., Sirpilla, Olivia, Yun, Kun, Stewart, Carli M., Can, Ismail, Ogbodo, Ekene J., Adada, Mohamad M., Kankeu Fonkoua, Lionel Aurelien, Hefazi, Mehrdad, Ruff, Michael W., Ilieva-Babinsky, Kristina, Augsberger, Christian, Patra-Kneuer, Maria, Heitmüller, Christina, Steidl, Stefan, Parikh, Sameer A., Ding, Wei, Kay, Neil E., Nowakowski, Grzegorz S, Siegler, Elizabeth L., Kenderian, Saad S.
Published in Transplantation and cellular therapy (01.02.2023)
Published in Transplantation and cellular therapy (01.02.2023)
Get full text
Journal Article
13 - Transient CD19 Occupancy with Tafasitamab at the Time of Anti-CD19 Chimeric Antigen Receptor T (CART19) Cell Infusion Diminishes Severity and Incidence of CRS and Improves the Therapeutic Index of CART19 Cell Therapy in Preclinical Models
Sakemura, R. Leo, Roman, Claudia Manriquez, Horvei, Paulina, Huynh, Truc N, Girsch, James H., Sirpilla, Olivia, Yun, Kun, Stewart, Carli M., Can, Ismail, Ogbodo, Ekene J., Adada, Mohamad M., Kankeu Fonkoua, Lionel Aurelien, Hefazi, Mehrdad, Ruff, Michael W., Ilieva-Babinsky, Kristina, Augsberger, Christian, Patra-Kneuer, Maria, Heitmüller, Christina, Steidl, Stefan, Parikh, Sameer A., Ding, Wei, Kay, Neil E., Nowakowski, Grzegorz S, Siegler, Elizabeth L., Kenderian, Saad S.
Published in Transplantation and cellular therapy (01.02.2023)
Published in Transplantation and cellular therapy (01.02.2023)
Get full text
Journal Article